FDA Extends Naloxone Shelf Life to 4 Years: What This Means for Overdose Response

The U.S. Food and Drug Administration (FDA) has extended the shelf life of over-the-counter 4 mg naloxone hydrochloride nasal spray (commonly known by the brand name Narcan) from 3 years to 4 years. This change, announced this week, applies to nonprescription naloxone products and has immediate implications for how individuals, families, and community organizations stock and maintain this life-saving medication.

What Changed

Previously, over-the-counter naloxone nasal spray carried a 3-year expiration date from the date of manufacture. The FDA's extension to 4 years means that newly manufactured products will now remain effective for an additional year before expiration. This change reflects stability data submitted to the FDA demonstrating that the medication maintains its potency and safety profile for the extended period when stored properly.

It is important to note that this extension applies specifically to the 4 mg naloxone hydrochloride nasal spray formulation approved for over-the-counter use. Other formulations, including higher-dose products and injectable naloxone, may have different shelf lives and storage requirements.

Why This Matters

Naloxone is an emergency medication that reverses opioid overdoses by displacing opioids from receptors in the brain and restoring normal breathing. In the context of the ongoing fentanyl crisis — where potent synthetic opioids are increasingly present in the unregulated drug supply — widespread naloxone access remains one of the most effective harm-reduction strategies available.

The shelf-life extension offers several practical benefits:

Reduced waste and cost: Organizations and individuals who maintain naloxone supplies will need to replace expired products less frequently, reducing both financial burden and medication waste.

Improved emergency preparedness: Families keeping naloxone at home for a loved one at risk of overdose can maintain their supply with greater confidence in its longevity.

Enhanced community distribution: Programs that distribute naloxone to community members, including harm-reduction organizations, first responders, and treatment facilities, can optimize their inventory management and potentially extend their reach with existing resources.

Storage Recommendations

While the shelf life has been extended, proper storage remains essential for maintaining naloxone's effectiveness. The FDA recommends storing naloxone at room temperature (between 59°F and 77°F, or 15°C to 25°C) and protecting it from light. Avoid storing naloxone in locations subject to extreme temperatures, such as vehicle glove compartments in hot weather or freezing outdoor environments.

Check your naloxone packaging periodically. If the liquid appears discolored or contains particles, or if the device appears damaged, replace it regardless of the expiration date.

What to Do in an Overdose Emergency

Naloxone is effective for reversing overdoses caused by opioids, including heroin, fentanyl, and prescription pain medications. However, it is important to understand its limitations:

1. Call 911 immediately: Naloxone is a temporary treatment. Emergency medical services are essential because the effects of naloxone may wear off before the opioids leave the person's system, potentially leading to a return of overdose symptoms.

2. Administer promptly: Follow the instructions on the device. Nasal spray formulations are designed for easy use by laypeople with minimal training.

3. Be prepared for multiple doses: Due to the extreme potency of fentanyl and its analogues, multiple doses of naloxone may be necessary to restore breathing. Continue administering doses every 2-3 minutes if breathing does not improve.

4. Position for safety: Place the person in the recovery position (on their side) to prevent choking if they vomit.

5. Stay until help arrives: Remain with the person until emergency responders arrive, as re-narcotization (return of overdose symptoms) can occur.

Accessing Naloxone

Naloxone is available without a prescription in all 50 states, though specific availability and cost vary:

• Pharmacies: Most major pharmacy chains stock over-the-counter naloxone. Some states have standing orders that allow pharmacists to dispense naloxone without an individual prescription.

• Community programs: Many harm-reduction organizations, health departments, and substance use treatment programs provide free naloxone and training on its use.

• Insurance coverage: Many insurance plans, including Medicaid in most states, cover naloxone with little or no copay. Check with your plan for specific coverage details.

• Mail-order options: Some organizations offer mail-order naloxone for individuals who cannot access it locally.

The Broader Context

This FDA action comes amid continued high rates of opioid-involved overdoses nationwide, though recent CDC data indicates a downward trend in overall overdose deaths for the third consecutive year. Public health experts attribute this decline partly to expanded naloxone distribution and harm-reduction efforts.

However, the unregulated drug supply remains unpredictable. Synthetic opioids, including fentanyl and emerging analogues, continue to drive overdose risk. Additionally, non-opioid substances such as xylazine and medetomidine — veterinary sedatives increasingly found in the drug supply — are not reversed by naloxone, complicating overdose response.

The shelf-life extension represents one component of a comprehensive overdose prevention strategy that includes expanded treatment access, harm-reduction services, and supply-side interventions.

Where to Get Help

If you or someone you know is struggling with substance use, help is available:

• SAMHSA National Helpline: 1-800-662-HELP (4357) — Free, confidential, 24/7 treatment referral and information
• Crisis Text Line: Text HOME to 741741
• 988 Suicide & Crisis Lifeline: Call or text 988
• FindTreatment.gov: Search for treatment providers by location and service type

For information on obtaining naloxone in your community, contact your local health department or visit the CDC's naloxone resource page.

This alert was medically reviewed by Dr. Rachel Bennett, MD, a board-certified addiction medicine physician. The information provided is for educational purposes and does not constitute medical advice. In an emergency, always call 911.